| Eyetrends | |
|
3525 Longmire Dr Ste K, College Station, TX 77845-5281 | |
| (979) 694-2000 | |
| (979) 694-2010 |
| Full Name | Eyetrends |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 3525 Longmire Dr Ste K, College Station, Texas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083862213 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 6652TG (Texas) | Primary |
| Provider Name | Simaan A Shini |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1093828436 PECOS PAC ID: 5092768218 Enrollment ID: I20050301000123 |
News Archive
Being aware of the health risks associated with treating menopausal symptoms might only make it harder for women to decide what to do.
With the rapid spread of the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world, causing the current COVID-19 pandemic, there is an urgent need for new antivirals and vaccines to combat its spread. The current study published on the preprint server bioRxiv in June 2020 shows some of the results of the extensive repurposing of already FDA-approved drugs.
The American Chemical Society (ACS) announced today that Courtney Aldrich, Ph.D., will head the brand-new, web-only journal ACS Infectious Diseases as editor-in-chief. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.
Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.
Seattle Genetics, Inc. today announced that it has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30 utilizing the company's proprietary ADC technology.
› Verified 3 days ago
| Provider Name | Dmitriy Zike |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861844615 PECOS PAC ID: 8022391242 Enrollment ID: I20170214002501 |
News Archive
Being aware of the health risks associated with treating menopausal symptoms might only make it harder for women to decide what to do.
With the rapid spread of the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world, causing the current COVID-19 pandemic, there is an urgent need for new antivirals and vaccines to combat its spread. The current study published on the preprint server bioRxiv in June 2020 shows some of the results of the extensive repurposing of already FDA-approved drugs.
The American Chemical Society (ACS) announced today that Courtney Aldrich, Ph.D., will head the brand-new, web-only journal ACS Infectious Diseases as editor-in-chief. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.
Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.
Seattle Genetics, Inc. today announced that it has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30 utilizing the company's proprietary ADC technology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eyetrends 3525 Longmire Dr Ste K, College Station, TX 77845-5281 Ph: (979) 694-2000 | Eyetrends 3525 Longmire Dr Ste K, College Station, TX 77845-5281 Ph: (979) 694-2000 |
News Archive
Being aware of the health risks associated with treating menopausal symptoms might only make it harder for women to decide what to do.
With the rapid spread of the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world, causing the current COVID-19 pandemic, there is an urgent need for new antivirals and vaccines to combat its spread. The current study published on the preprint server bioRxiv in June 2020 shows some of the results of the extensive repurposing of already FDA-approved drugs.
The American Chemical Society (ACS) announced today that Courtney Aldrich, Ph.D., will head the brand-new, web-only journal ACS Infectious Diseases as editor-in-chief. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.
Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.
Seattle Genetics, Inc. today announced that it has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30 utilizing the company's proprietary ADC technology.
› Verified 3 days ago
Vision Insight Corporation Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1405 Earl Rudder Fwy S, College Station, TX 77845 Phone: 979-764-7700 Fax: 979-764-7701 | |
Kathryn L Yorke, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2551 Texas Ave S Ste B, College Station, TX 77840 Phone: 979-764-0669 Fax: 979-694-1940 | |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1505 University Dr E Ste 450, College Station, TX 77840 Phone: 979-431-6053 | |
Dr. Michael C. Brice, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1700 University Dr E, College Station, TX 77840 Phone: 979-691-3300 | |
Dr. Don W. Nicholson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1700 University Dr E, College Station, TX 77840 Phone: 979-691-3300 Fax: 979-691-3527 | |
Dr. Justin Mays, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1109 Rock Prairie Rd Ste 300, College Station, TX 77845 Phone: 979-764-0669 Fax: 979-694-1940 | |
Dr Ann L Wild, Optometrist Optometrist Medicare: Medicare Enrolled Practice Location: 2746 Longmire Dr, College Station, TX 77845 Phone: 979-764-1554 Fax: 979-694-2259 |